Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis
Lillia A Baird1,2, Haley McQuown1, Jihyun Park1
1Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Annals of Clinical and Translational Neurology
|May 15, 2026
Summary
Neutrophil extracellular trap (NET) formation is increased in amyotrophic lateral sclerosis (ALS) and linked to poorer survival in females. This suggests NETs may be a key mechanism in ALS progression, especially for women.
Area of Science:
- Neuroscience
- Immunology
Background:
- Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) are inversely correlated with survival.
- Neutrophils may play a role in ALS disease progression.
Purpose of the Study:
- Characterize markers of neutrophil activation pathways in ALS.
- Evaluate associations between these markers and ALS survival.
- Identify potential mechanisms of neutrophil involvement in ALS.
Main Methods:
- Quantified spontaneous ex vivo neutrophil extracellular trap (NET) formation via image analysis.
- Measured plasma levels of neutrophil activation markers: calprotectin, matrix-metalloproteinase 9 (MMP9), and neutrophil gelatinase-associated lipocalin (NGAL).
- Assessed NET formation via double-stranded DNA (dsDNA) fluorescence assay.
- Associated markers with ALS survival using Cox proportional hazard regression, stratified by sex.
Main Results:
- Spontaneous ex vivo NET formation was significantly increased in ALS patients compared to controls.
- Plasma levels of calprotectin, MMP9, and NGAL were elevated in ALS patients.
- Calprotectin, MMP9, and NGAL levels were not associated with ALS survival.
- Elevated dsDNA levels, indicative of NET formation, were associated with poorer ALS survival, specifically in females.
Conclusions:
- Neutrophil function is demonstrably altered in individuals with ALS.
- NET formation represents a potential mechanism by which neutrophils contribute to ALS pathogenesis.
- The association between NETs and survival suggests a particular role for this pathway in female ALS patients.


